VANCOUVER, Wash. and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Guggenheim Securities SMID Cap Biotech Conference in New York, NY.
Read more at globenewswire.comAbsci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
ABSCI CORP
NASDAQ:ABSI (2/11/2025, 2:58:04 PM)
4.74
+0.41 (+9.47%)
ABSI Latest News and Analysis
20 days ago - ChartmillCurious about what's happening in today's session? Check out the latest stock movements and price changes.Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
20 days ago - ChartmillGapping stocks in Wednesday's sessionLet's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
